LGND
#1189
Ligand Pharmaceuticals Incorporated - Common Stock
311.7 9 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.41%
Monthly Change
+22.28%
6 month change
+50.03%
Year Change
+66.63%
Previous Close
316.2 4
Open
311.0 0
Low
310.9 5
High
312.6 0
Volume
31
Financials
- Market Capitalization 6.25 B
- Employee 47
- Founded N/A
- CEO N/A
- Website www.ligand.com
- Headquarter Delaware, United States
- FIGI BBG000BKF014
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
26.03
Price to sales ratio
14.76
Dividends per share
—
Dividend yield %
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1165 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 67.00 USD | -2.79% | +11.09% | +28.80% | +64.26% | 6.48 B USD | ||
| 1174 |  COGT Cogent Biosciences, Inc. - Common Stock | 37.35 USD | -3.91% | -5.13% | +14.71% | +138.35% | 6.38 B USD | ||
| 1191 |  LQDA Liquidia Corporation - Common Stock | 70.78 USD | -9.17% | -11.84% | +0.55% | +213.19% | 6.29 B USD | ||
| 1252 |  BLTE Belite Bio Inc - American Depositary Shares | 147.03 USD | -1.54% | -5.14% | +6.83% | +132.79% | 5.78 B USD |
Frequently asked questions about Ligand Pharmaceuticals Incorporated - Common Stock
What is the Ligand Pharmaceuticals Incorporated - Common Stock stock price today?
The current price of Ligand Pharmaceuticals Incorporated - Common Stock (LGND) is 311.79. Over the past 24 hours, the stock has changed by -1.41%. Follow the LGND chart for real-time price dynamics.
What is the stock ticker of Ligand Pharmaceuticals Incorporated - Common Stock?
Ligand Pharmaceuticals Incorporated - Common Stock trades under the ticker LGND. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ligand Pharmaceuticals Incorporated - Common Stock stock going up?
LGND has changed by -2.31% over the last week, +22.28% over the last month, and +66.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Ligand Pharmaceuticals Incorporated - Common Stock release financial reports?
Yes. You can track Ligand Pharmaceuticals Incorporated - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Ligand Pharmaceuticals Incorporated - Common Stock net income for the last quarter?
Ligand Pharmaceuticals Incorporated - Common Stock reported net income of -13.35 M for the last quarter. The previous quarter showed 44.78 M, which means net income changed by -129.80%.
How many employees does Ligand Pharmaceuticals Incorporated - Common Stock have?
As of the latest available data, Ligand Pharmaceuticals Incorporated - Common Stock has 47 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ligand Pharmaceuticals Incorporated - Common Stock EBITDA?
Ligand Pharmaceuticals Incorporated - Common Stock EBITDA is -6.62 M, and its EBITDA margin is -12.8%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ligand Pharmaceuticals Incorporated - Common Stock stock?
You can buy Ligand Pharmaceuticals Incorporated - Common Stock (LGND) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ligand Pharmaceuticals Incorporated - Common Stock stock?
Investing in Ligand Pharmaceuticals Incorporated - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LGND chart and related analysis on metatrader.com as part of your research.